Informations générales
  • Catégorie de maladie Maladies endocriniennes (hors cancer) (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Lausanne
    (BASEC)
  • Responsable de l'étude Heba Al-Alwan heba.al-alwan@chuv.ch (BASEC)
  • Source(s) de données BASEC: Importé de 26.06.2025 ICTRP: N/A
  • Date de mise à jour 26.06.2025 12:50
HumRes66673 | SNCTP000006362 | BASEC2024-02221

The effectiveness of insulin administration with an insulin pump using a fully closed-loop system on renal oxygenation in people with type 2 diabetes suffering from moderate chronic kidney disease

  • Catégorie de maladie Maladies endocriniennes (hors cancer) (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Lausanne
    (BASEC)
  • Responsable de l'étude Heba Al-Alwan heba.al-alwan@chuv.ch (BASEC)
  • Source(s) de données BASEC: Importé de 26.06.2025 ICTRP: N/A
  • Date de mise à jour 26.06.2025 12:50

Résumé de l'étude

Chronic kidney disease is a common complication of diabetes, affecting up to 40% of diabetic patients. Renal hypoxia is likely involved in the development of diabetic nephropathy. Higher blood sugar levels have been shown to be associated with decreased renal oxygenation. Blood oxygen level-dependent (BOLD) MRI is a new functional imaging technique that allows for non-invasive assessment of renal oxygenation. The administration of insulin in a fully closed-loop system in patients with type 2 diabetes has shown improvement in glycemic control. However, no study has evaluated the effect of a fully closed-loop system on renal function. This study is a randomized controlled trial aimed at assessing the effect of using an insulin pump with a fully closed-loop system on renal function in patients with type 2 diabetes suffering from moderate chronic kidney disease. 76 patients with type 2 diabetes and chronic kidney disease who are receiving insulin treatment will be invited to participate in this study. Half of the participants will be placed on treatment with an insulin pump using a fully closed-loop system and monitored for a duration of 26 weeks. The other half will continue their usual treatment with insulin injections. Renal oxygenation will be assessed at the end of the 26 weeks using BOLD MRI. Patient-reported outcomes will also be evaluated in both groups.

(BASEC)

Intervention étudiée

Chronic kidney disease is a common complication of diabetes, affecting up to 40% of diabetic patients. Renal hypoxia is likely involved in the development of diabetic nephropathy. Higher blood sugar levels have been shown to be associated with decreased renal oxygenation. Blood oxygen level-dependent (BOLD) MRI is a new functional imaging technique that allows for non-invasive assessment of renal oxygenation. The administration of insulin in a fully closed-loop system in patients with type 2 diabetes has shown improvement in glycemic control. However, no study has evaluated the effect of a fully closed-loop system on renal function.

 

This study is a randomized controlled trial aimed at assessing the effect of using an insulin pump with a fully closed-loop system on renal function in patients with type 2 diabetes suffering from moderate chronic kidney disease. 76 patients with type 2 diabetes and chronic kidney disease who are receiving insulin treatment will be invited to participate in this study. Half of the participants will be placed on treatment with an insulin pump using a fully closed-loop system and monitored for a duration of 26 weeks. The other half will continue their usual treatment with insulin injections. Renal oxygenation will be assessed at the end of the 26 weeks using BOLD MRI. Patient-reported outcomes will also be evaluated in both groups.

(BASEC)

Maladie en cours d'investigation

Type 2 diabetes, chronic kidney disease

(BASEC)

Critères de participation
Type 2 diabetes Chronic kidney disease stage III Insulin treatment (BASEC)

Critères d'exclusion
Type 1 diabetes Contraindication to perform an MRI Two episodes of hypoglycemia in the last six months (BASEC)

Lieu de l’étude

Lausanne

(BASEC)

non disponible

Sponsor

The Principal Investigator (PI) acts as the Sponsor

(BASEC)

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

Heba Al-Alwan

+41795562798

heba.al-alwan@chuv.ch

CHUV

(BASEC)

Informations scientifiques

non disponible

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Commission cantonale d'éthique du Vaud

(BASEC)

Date d'approbation du comité d'éthique

10.04.2025

(BASEC)


Identifiant de l'essai ICTRP
non disponible

Titre officiel (approuvé par le comité d'éthique)
The effect of fully closed-loop insulin delivery on renal oxygenation in people with type 2 diabetes and chronic kidney disease: an open-label, single-center, randomized two-arm parallel trial (CLICK study) (BASEC)

Titre académique
non disponible

Titre public
non disponible

Maladie en cours d'investigation
non disponible

Intervention étudiée
non disponible

Type d'essai
non disponible

Plan de l'étude
non disponible

Critères d'inclusion/exclusion
non disponible

non disponible

Critères d'évaluation principaux et secondaires
non disponible

non disponible

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
non disponible

Contacts supplémentaires
non disponible

ID secondaires
non disponible

Résultats-Données individuelles des participants
non disponible

Informations complémentaires sur l'essai
non disponible

Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible